Abdel-Razeq R - Search Results

1

Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with Helicobacter pylori infection: A population-based study.

Abdel-Razeq R, Bitar L, Bitar ER, Onwuzo C, Abu-Hammour MN, Eren B, Mohamed I, Johnson A, Boustany A, Onwuzo S, Asaad I. Abdel-Razeq R, et al. World J Hepatol. 2024 Oct 27;16(10):1169-1176. doi: 10.4254/wjh.v16.i10.1169. World J Hepatol. 2024. PMID: 39474577 Free PMC article.

2

PROTON-PUMP INHIBITORS ARE ASSOCIATED WITH AN INCREASED RISK OF MICROSCOPIC COLITIS: A POPULATION-BASED STUDY AND REVIEW OF THE LITERATURE.

Abdel-Razeq R, Boustany A, Onwuzo S, Saleh M, Gupta R, Zeid HKA, Onwuzo CN, Farhat D, Najjar M, El Alayli A, Asaad I. Abdel-Razeq R, et al. Arq Gastroenterol. 2024 Oct 21;61:e24053. doi: 10.1590/S0004-2803.24612024-053. eCollection 2024. Arq Gastroenterol. 2024. PMID: 39442126 Free article.

3

Survival Outcomes after Placement of Inferior Vena Cava Filters in Cancer Patients: Insights from a Comprehensive Cancer Center's Experience.

Abdel-Razeq H, Tamimi F, Al-Jaghbeer MJ, Sharaf B, Abdel-Razeq R, Bani Issa J, Abu-Jaish H, Salama O. Abdel-Razeq H, et al. Among authors: abdel razeq r. J Clin Med. 2023 Nov 21;12(23):7209. doi: 10.3390/jcm12237209. J Clin Med. 2023. PMID: 38068260 Free PMC article.

4

A Durable Response of Primary Advanced Colonic Plasmacytoma Using a Combination of Surgical Resection and Adjuvant Bortezomib: A Case Report and Literature Review.

Alfar R, Kamal N, Abdel Razeq R, Omari Z, Bater R, Sharaf B. Alfar R, et al. Among authors: abdel razeq r. Onco Targets Ther. 2022 Nov 7;15:1347-1354. doi: 10.2147/OTT.S372534. eCollection 2022. Onco Targets Ther. 2022. PMID: 36388154 Free PMC article.

5

Care Needs and Symptoms Burden of Breast Cancer Patients in Jordan: A Cross-Sectional Study.

Shamieh O, Alarjeh G, Li H, Abu Naser M, Abu Farsakh F, Abdel-Razeq R, Edilbi A, Al-Ani R, Harding R, Guo P. Shamieh O, et al. Among authors: abdel razeq r. Int J Environ Res Public Health. 2022 Aug 30;19(17):10787. doi: 10.3390/ijerph191710787. Int J Environ Res Public Health. 2022. PMID: 36078504 Free PMC article.

6

Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.

Halahleh K, Al Sawajneh S, Saleh Y, Shahin O, Abufara A, Ma'koseh M, Abdel-Razeq R, Barakat F, Abdelkhaleq H, Al-Hassan N, Atiyyat R, Al-Faker N, Omari Z, Ghatasheh H, Jaradat I, Muradi I, Iyad S, Bazarbachi A. Halahleh K, et al. Among authors: abdel razeq r. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):589-595. doi: 10.1016/j.clml.2022.02.009. Epub 2022 Mar 4. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35490153

7

Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years.

Alsughayer AM, Dabbagh TZ, Abdel-Razeq RH, Al-Jussani GN, Alhassoon S, Sughayer MA. Alsughayer AM, et al. Among authors: abdel razeq rh. JCO Glob Oncol. 2022 Mar;8:e2100359. doi: 10.1200/GO.21.00359. JCO Glob Oncol. 2022. PMID: 35436143 Free PMC article.

8

Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives.

Abdel-Razeq H, Tamimi F, Abujamous L, Abdel-Razeq R, Abunasser M, Edaily S, Abdulelah H, Khashabeh RA, Bater R. Abdel-Razeq H, et al. Among authors: abdel razeq r. Front Oncol. 2022 Mar 25;12:673094. doi: 10.3389/fonc.2022.673094. eCollection 2022. Front Oncol. 2022. PMID: 35402282 Free PMC article.

9

Urinary bladder metastasis from primary breast cancer, a rare and challenging diagnosis. A case report and literature review.

Abdel-Razeq R, AlMasri R, Abunasser M, Edaily S, Jaber O, Khader O, Ghanem R, Abdel-Razeq H. Abdel-Razeq R, et al. Ann Med Surg (Lond). 2022 Mar 3;76:103455. doi: 10.1016/j.amsu.2022.103455. eCollection 2022 Apr. Ann Med Surg (Lond). 2022. PMID: 35308426 Free PMC article.

10

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data.

Abdel-Razeq H, Sharaf B, AlMasri R, Abdel-Razeq R, Tamimi F, Khader O, Salama O, Abunasser M, Edaily S, Abdulelah H. Abdel-Razeq H, et al. Among authors: abdel razeq r. Cancer Manag Res. 2022 Mar 8;14:1033-1041. doi: 10.2147/CMAR.S353584. eCollection 2022. Cancer Manag Res. 2022. PMID: 35300061 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters